Patent Oppositions in protein and peptide compounds industry

Explore the competitive field of protein and peptide compounds where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in protein and peptide compounds technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the protein and peptide compounds industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the protein and peptide compounds industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Feb 19, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Multispecific Antigen-Binding Molecule With Improved Internalization CharacteristicsGENMABJan 9, 2026ELKINGTON AND FIFE
Chimeric Antigen Receptors Targeting B-Cell Maturation AntigenTHE USA REPRESENTED BY THE SECRETARYDec 31, 2025BOULT WADE TENNANT
Dosing Regimen Of Anti-Alpha4Beta7-AntibodiesMILLENNIUM PHARMACEUTICALSDec 19, 2025GRAF VON STOSCH PATENTANWALTSGESELLSCHAFT
Tangential Flow Filtration Process For Concentrating Biomolecule SolutionsFUJIFILM DIOSYNTH BIOTECHNOLOGIES UKDec 19, 2025SARTORIUS STEDIM BIOTECH
Combinations Of Cabozantinib And Atezolizumab To Treat CancerEXELIXISDec 19, 2025STADA ARZNEIMITTEL
Targeted Lipid Particles For Systemic Delivery Of Nucleic Acid Molecules To LeukocytesRAMOT AT TEL AVIV UNIVERSITYDec 18, 2025KARO
Dosing Regimen Of Anti-Alpha4Beta7-AntibodiesMILLENNIUM PHARMACEUTICALSDec 18, 2025ABEL & IMRAY
Dosing Regimen Of Anti-Alpha4Beta7-AntibodiesMILLENNIUM PHARMACEUTICALSDec 17, 2025BRAND MURRAY FULLER
Targeted Lipid Particles For Systemic Delivery Of Nucleic Acid Molecules To LeukocytesRAMOT AT TEL AVIV UNIVERSITYDec 15, 2025STRAWMAN
A Myostatin Pathway Inhibitor In Combination With A Glp-1 Pathway Activator For Use In Treating Metabolic DisordersSCHOLAR ROCKDec 3, 2025MARGARET DIXON

To stay ahead in the competitive protein and peptide compounds industry, companies are constantly innovating. Here are the top patents facing oppositions in the protein and peptide compounds industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Feb 19, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Nov 21, 2018Formulation Of Boronic Acid CompoundsTHE UNITED STATES OF AMERICA12
Nov 1, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH11
Jan 10, 2018Method To Improve Virus Removal In Protein PurificationF HOFFMANN LA ROCHE11
May 15, 2019Combination Therapy For The Treatment Of Ovarian CancerF HOFFMANN LA ROCHE10
Sep 19, 2018Methods Of Cell CultureMOMENTA PHARMACEUTICALS10
Feb 17, 2021Pharmaceutical Composition For Cancer TreatmentSHIONOGI10
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA10
Feb 17, 2021Subcutaneously Administered Bispecific Antibodies For Use In The Treatment Of CancerLINDIS BIOTECH10
Nov 29, 2017Prevention Of Disulfide Bond Reduction During Recombinant Production Of PolypeptidesGENENTECH9
May 15, 2019Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF HOFFMANN LA ROCHE9